Ideagen PLC Director Dealings (0915W)

TIDMIDEA

RNS Number : 0915W

Ideagen PLC

12 April 2019

Ideagen PLC

("Ideagen," "the Company" or the "Group")

Director Dealing

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that Alan Carroll, a non-executive director, yesterday purchased 48 ordinary shares in the Company at a price of 150.5 pence each as a result of the automatic reinvestment of the Company's recent dividend by his nominated broker.

Following the purchase, Mr Carroll's beneficial interest has increased to 204,171 shares representing approximately 0.1% of the Company's issued ordinary share capital.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

Enquiries:

 
Ideagen plc                          01629 699100 
David Hornsby, Executive Chairman 
Ben Dorks, Chief Executive 
Graeme Spenceley, Finance Director 
 
finnCap Limited                      020 7220 0500 
Henrik Persson/James Thompson 
 (Nomad) 
Alice Lane (ECM) 
Canaccord Genuity                    020 7523 8000 
Simon Bridges 
Ben Griffiths 
Jack Haynes 
 

About Ideagen plc

Ideagen is a UK-headquartered, global technology company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

The Group provides software and services to organisations operating within highly regulated industries such as aviation, banking and finance and life science, with its main operational premises spread throughout the UK, EU, US, Middle East and SE Asia.

With an excellent portfolio of software products including Q-Pulse, Coruson, Pentana Audit and PleaseReview, Ideagen helps its clients reduce costs, improve operational efficiency, strengthen compliance and oversight and anticipate and manage every detail of risk.

Currently, more than 4,700 organisations use Ideagen's products including seven of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of the world's leading pharmaceutical firms.

Ideagen's diverse and varied customer base includes many well-known, global brands such as British Airways, Aggreko, BAE, Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank, Meggitt, Heineken, Johnson Matthey, Haeco Group and European Central Bank. As well as this, Ideagen counts 180 hospitals across the UK and US amongst its client base.

For further information please visit www.ideagen.com.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1.   Details of the person discharging managerial responsibilities / person closely associated 
 a)   Name                                                      Alan Carroll 
     --------------------------------------------------------  ------------------------------------------------------- 
 2.   Reason for the Notification 
     ----------------------------------------------------------------------------------------------------------------- 
 a)   Position/status                                           Non-Executive Director 
     --------------------------------------------------------  ------------------------------------------------------- 
 b)   Initial notification/Amendment                            Initial notification 
     --------------------------------------------------------  ------------------------------------------------------- 
 3.   Details of the issuer, emission allowance market participant, auction platform, auctioneer 
       or auction monitor 
     ----------------------------------------------------------------------------------------------------------------- 
 a)   Name                                                      Ideagen plc 
     --------------------------------------------------------  ------------------------------------------------------- 
 b)   LEI                                                       213800KS1MLITOVNYC85 
     --------------------------------------------------------  ------------------------------------------------------- 
 4.   Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; and (iv) each place where transactions have been 
       conducted 
     ----------------------------------------------------------------------------------------------------------------- 
 a)   Description of the Financial instrument, type of          Ordinary Shares of 1p each 
      instrument 
     --------------------------------------------------------  ------------------------------------------------------- 
      Identification code                                       GB00B0CM0C50 
     --------------------------------------------------------  ------------------------------------------------------- 
 b)   Nature of the transaction                                 Purchase of Ordinary Shares 
     --------------------------------------------------------  ------------------------------------------------------- 
 c)   Price(s) and volume(s)                                    Price(s)  Volume(s) 
                                                                 150.5p    48 
     --------------------------------------------------------  ------------------------------------------------------- 
 d)   Aggregated information:                                    48 ordinary shares of 1p each purchased at 150.5p per 
       -- Aggregated volume                                      share 
       -- Price 
     --------------------------------------------------------  ------------------------------------------------------- 
 e)   Date of the transaction                                   11 April 2019 
     --------------------------------------------------------  ------------------------------------------------------- 
 f)   Place of the transaction                                  London Stock Exchange AIM market (XLON) 
     --------------------------------------------------------  ------------------------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHGGUPCCUPBGWP

(END) Dow Jones Newswires

April 12, 2019 09:43 ET (13:43 GMT)